Yesterday's Webinar question....My reception was not the best at times.....However, I recall PL saying something to the effect that he was unsure the best way to describe it, he then stated (what I thought was) "it's a healing drug". M y question is....Was he refering to plasminogen by itself, in combination with PBI 4050 or was it just PBI 4050 by itself?
Also there was mention of IAIP.......so I reviewed some past NR....this one came out just prior to that New York presentation. https://prometic.com/prometic-enters-into-strategic-agreements-with-prothera-biologics-to-develop-plasma-derived-inter-alpha-inhibitor-proteins-iaip-for-orphan-diseases/
I thought it it was worth review because it was part of the lead up before attending NY.
Just thinking about what makes these houses click......I believe it was Panmure Gordon which stated a price projection somewhere near $6.25 if Prometic was able to get any 2 indications approved.....I took that at the time as meaning maybe CKD and Alstrom.
After a little more thought it probably meant PBI 4050 and Plasminogen...If this reasoning is good...we are probably getting very close to a breakout as our pipeline has a lot going forward...the next 3 years should be fun and won't be selling into any stink takeovers.
foof